Efficacy evaluation of a fermented milk containing inactivated biomasses of Lacticaseibacillus rhamnosus and Saccharomyces cerevisiae to ameliorate the toxic effects of dietary aflatoxins and fumonisins in pigs: a pilot study

Freire, Lucas Gabriel Dionisio, Silva, Jennifer Rafaela Sá, Assis, Lucas Luiz, Ramalho, Leandra Náira Zambelli, Ramalho, Fernando Silva, Budiño, Fabio Enrique Lemos, Pereira, Karina Nascimento, Pires, Rogério D’Antonio, Ullah, Sana, Ali, Sher, Ghantous, Giovana Fumes, Rosim, Roice Eliana, Corassin, Carlos Humberto, Oliveira, Carlos Augusto Fernandes
Mycotoxin Research · Springer Nature · 2026-09-04 · DOI: 10.1007/s12550-026-00677-7

Abstract

Inactivated microorganisms may reduce mycotoxins’ bioavailability, although in vivo evidence is limited especially in farm animals. This pilot study evaluated whether a fermented milk (FM) containing heat-inactivated biomasses of Lacticaseibacillus rhamnosus and Saccharomyces cerevisiae at 1% ( w/w ) mitigated the toxic effects of dietary aflatoxins (AFs) and fumonisins (FBs) in weaned piglets. Twenty-four male crossbred piglets were assigned to a 2 × 2 × 2 factorial design ( n = 3 per group) with AFs (0; 1.11–1.28 mg/kg, sum of AFB_1, AFB_2, AFG_1 and AFG_2), FBs (0.78–0.99; 9.22–9.53 mg/kg, sum of FB_1 and FB_2), and FM (0; 39 g/animal/day, equivalent to 5% of basal diet) for 28 days. AFs reduced ( P < 0.05) the body weight gain and feed consumption. AFs or AFs + FBs exposure were associated with hepatic lesions, whereas FBs caused increased pulmonary and renal lesions ( P < 0.05). FM was associated with lower ( P < 0.05) scores of FBs’ lung lesions and AFs + FBs’ kidney lesions, but did not consistently improve growth performance or hepatic and renal biochemical parameters. Plasma AFP_1 and urinary FB_2 were lower ( P < 0.05) in AFs- or FBs-exposed animals receiving FM, while plasma and urinary AFM_1 or FB_1 were not reduced by the FM. In conclusion, FM containing inactivated L. rhamnosus and S. cerevisiae had partial protective effects against organ-specific mycotoxin injury, with limited evidence of AFs bioavailability reduction, considering n = 3 per experimental group. Further studies should evaluate different inclusion levels of microorganisms and mycotoxins, as well as other potentially adsorptive microorganisms, with a focus on microorganism–mycotoxin interactions within the gastrointestinal tract.

Read at publisher →

Similar articles